Tag Archives: BAYRY

Bayer Aktiengesellschaft (BAYRY)

Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. The Consumer Health segment is engaged in the development....More>>>

News about BAYRY

Rheinmetall: Business Separation Can Unlock Significant Value
From:seekingalpha.com
Rheinmetall (OTCPK:RNMBY) has a balanced business within the automotive and defense sectors. However, its defense segment has better growth prospects and a more solid business position than its automotive segment. This profile creates undervaluation ...Read More>>>

Keytruda Gets Hot And Propels Merck: Analysis
From:seekingalpha.com
Background The venerable Merck (NYSE:MRK) has turned into a hot mega-cap stock again, at least hot for a non-Internet stock, on the back of its immuno-oncology drug Keytruda. Here's a look at MRK's movement - up almost 70%, plus dividends, in five ye...Read More>>>

Why Indian Startups Are Targeting This New $5 Billion Market
From:moneymorning.com
Right now, there's a billion-dollar profit opportunity big pharma companies are completely ignoring: reversible male contraceptives. Bloomberg projects this form of contraceptive could cut into half of the $10 billion global female contracep...Read More>>>

J&J Now Too Cheap To Its Peers To Ignore
From:seekingalpha.com
Background Far and away the world's largest healthcare company, and with many or most of its consumer brands also medicines or health-related, Johnson & Johnson (NYSE:JNJ) would normally, in my humble view, trade at a premium to the S&P 500 (...Read More>>>

Could Nektar Therapeutics Be Worth More?"
From:www.fool.com
Nektar Therapeutics (NASDAQ:NKTR) is an intriguing commercial-stage biotech company that's just reported positive late-stage trial results for its pain-busting drug NKTR-181. However, shares have jumped on the news, and the company's market cap has s...Read More>>>